Key metrics and charts across all fundamental categories.
Stock price and market valuation
BLDR trades at $84.7, a 32.2% decrease year-over-year. Market capitalization stands at $9.31B, down 34.5% from the prior year. Track BLDR price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$14.82B in TTM revenue declined 8.3% YoY, reaching $3.29B last quarter. TTM EBITDA of $1.51B on operating income of $16.52M shows growth is flowing through. Net income of $291.48M TTM confirms the company is converting revenue into profit. Revenue is contracting — assess whether this is cyclical or structural.
Assets, cash, debt, and leverage
With $11.30B in assets and $4.61B in long-term debt, the D/E of 1.2 reflects moderate leverage — debt is manageable but worth monitoring.
Price multiples and return ratios
At 31.9x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 0.6x and P/B of 2.3x provide additional context. The premium P/E is not backed by strong revenue growth — the stock may be overvalued.
Operating efficiency and return metrics
Op. margin of 0.5% is down 4.5% YoY — costs are rising relative to revenue. Net margin at -1.4% and gross margin of 28.3%. ROE of 7.3% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $40.71M on $87.45M in operating cash flow. The FCF / Net Income ratio of 0.1x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $98.34M provide financial flexibility. Shares outstanding declined 3.3% YoY — buybacks are returning capital to shareholders.
